Eli Lilly Japan Seeking Additional Approval for Pemetrexed and Cisplatin.Tokyo, Japan, June 28, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Eli Lilly Japan has filed an application for pemetrexed and cisplatin cisplatin /cis·plat·in/ (sis´plat-in) DDP; a platinum coordination complex capable of producing inter- and intrastrand DNA crosslinks; used as an antineoplastic. cis·plat·in n. , two antitumor agents, with the Ministry of Health, Labor and Welfare. Pemetrexed and cisplatin are indicated for the treatment of malignant pleural Pleural Pleural refers to the pleura or membrane that enfolds the lungs. Mentioned in: Pneumothorax pleural emanating from or pertaining to the pleura. mesothelioma Mesothelioma Definition Mesothelioma is an uncommon disease that causes malignant cancer cells to form within the lining of the chest, abdomen, or around the heart. Its primary cause is believed to be exposure to asbestos. . Initially approved in the US in 2004, the combination therapy - the only of its kind - is now available in over 70 countries worldwide. Malignant pleural mesothelioma, which is related to asbestos exposure, is a cancer that is difficult to treat. In Japan, the number of malignant pleural mesothelioma patients is growing and is not expected to peak until 2030. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion